Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting.

Heidelbaugh JJ, Goldberg KL, Inadomi JM.

Am J Manag Care. 2010 Sep;16(9):e228-34.

PMID:
21250399
2.

Trends in gastroesophageal reflux disease as measured by the National Ambulatory Medical Care Survey.

Friedenberg FK, Hanlon A, Vanar V, Nehemia D, Mekapati J, Nelson DB, Richter JE.

Dig Dis Sci. 2010 Jul;55(7):1911-7. doi: 10.1007/s10620-009-1004-0. Epub 2009 Oct 15.

PMID:
19830561
3.

Proton pump inhibitor utilization patterns in infants.

Barron JJ, Tan H, Spalding J, Bakst AW, Singer J.

J Pediatr Gastroenterol Nutr. 2007 Oct;45(4):421-7.

PMID:
18030207
4.

Appropriate proton pump inhibitor use among older adults: a retrospective chart review.

George CJ, Korc B, Ross JS.

Am J Geriatr Pharmacother. 2008 Dec;6(5):249-54. doi: 10.1016/j.amjopharm.2008.12.001.

PMID:
19161927
5.

Non-steroidal anti-inflammatory drug prescriptions in hospital inpatients: are we assessing the risks?

Kitchen J, Kane D.

Ir J Med Sci. 2010 Sep;179(3):357-60. doi: 10.1007/s11845-010-0496-0. Epub 2010 May 30.

PMID:
20512664
6.

Do hospitalists overuse proton pump inhibitors? Data from a contemporary cohort.

Albugeaey M, Alfaraj N, Garb J, Seiler A, Lagu T.

J Hosp Med. 2014 Nov;9(11):731-3. doi: 10.1002/jhm.2249. Epub 2014 Aug 14. No abstract available.

7.

Potential influence of antisecretory therapy on the development of Candida-associated intraabdominal infection.

Cat TB, Charash W, Hebert J, Marden BT, Corbett SM, Ahern J, Rebuck JA.

Ann Pharmacother. 2008 Feb;42(2):185-91. doi: 10.1345/aph.1K328. Epub 2008 Jan 22.

PMID:
18212256
8.

[Gastroesophageal reflux and proton pump inhibitors: panacea or prescription abuse?].

Mouterde O, Bellaïche M, Dumant C, Mallet E.

Arch Pediatr. 2010 Jun;17(6):739-40. doi: 10.1016/S0929-693X(10)70086-5. French. No abstract available.

PMID:
20654868
9.

Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease.

Choudhry MN, Soran H, Ziglam HM.

QJM. 2008 Jun;101(6):445-8. doi: 10.1093/qjmed/hcn035. Epub 2008 Apr 14.

PMID:
18411220
10.

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.

Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D.

Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. Review.

11.

Potentially inappropriate prescribing for elderly patients in 2 outpatient settings.

Maio V, Hartmann CW, Poston S, Liu-Chen X, Diamond J, Arenson C.

Am J Med Qual. 2006 May-Jun;21(3):162-8.

PMID:
16679435
12.

Prescribing of anti-osteoporotic therapies following the use of proton pump inhibitors in general practice.

McGowan B, Bennett K, Barry M.

Pharmacoepidemiol Drug Saf. 2010 Jul;19(7):763-9. doi: 10.1002/pds.1972.

PMID:
20582909
13.

Use of intravenous proton-pump inhibitors in a teaching hospital practice.

Hoover JG, Schumaker AL, Franklin KJ.

Dig Dis Sci. 2009 Sep;54(9):1947-52. doi: 10.1007/s10620-008-0568-4. Epub 2008 Nov 26.

PMID:
19034652
14.

Socio-demographic factors influence chronic proton pump inhibitor use by a large population in the Netherlands.

van Boxel OS, Hagenaars MP, Smout AJ, Siersema PD.

Aliment Pharmacol Ther. 2009 Mar 1;29(5):571-9. doi: 10.1111/j.1365-2036.2008.03900.x. Epub 2008 Nov 25.

15.

Overuse of proton pump inhibitors.

Naunton M, Peterson GM, Bleasel MD.

J Clin Pharm Ther. 2000 Oct;25(5):333-40.

PMID:
11123484
16.

Inappropriate use of proton pump inhibitors in a local setting.

Chia CT, Lim WP, Vu CK.

Singapore Med J. 2014 Jul;55(7):363-6.

17.

Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?

Hemmink GJ, Bredenoord AJ, Weusten BL, Monkelbaan JF, Timmer R, Smout AJ.

Am J Gastroenterol. 2008 Oct;103(10):2446-53. doi: 10.1111/j.1572-0241.2008.02033.x. Epub 2008 Aug 5.

PMID:
18684197
18.

Proton pump inhibitor therapy does not affect hydrogen production on lactulose breath test in subjects with IBS.

Law D, Pimentel M.

Dig Dis Sci. 2010 Aug;55(8):2302-8. doi: 10.1007/s10620-009-1010-2. Epub 2009 Oct 16.

PMID:
19834807
19.
20.

Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.

Bajaj JS, Zadvornova Y, Heuman DM, Hafeezullah M, Hoffmann RG, Sanyal AJ, Saeian K.

Am J Gastroenterol. 2009 May;104(5):1130-4. doi: 10.1038/ajg.2009.80. Epub 2009 Mar 31.

PMID:
19337238

Supplemental Content

Support Center